Keyphrases
26S Proteasome
33%
Allelic Variants
66%
Alpha-1 Antitrypsin
33%
Associated Proteins
33%
Biochemical Analysis
66%
CFTR Protein
33%
Cystic Fibrosis
33%
Degradation Pathway
33%
Deubiquitinating Enzyme
100%
Disease Symptoms
33%
Emphysema
33%
Endoplasmic Reticulum
100%
Endoplasmic Reticulum-associated Degradation
66%
Genetic Analysis
33%
Hereditary Disease
33%
Homozygous Familial Hypercholesterolemia (HoFH)
33%
Insulin Receptor
33%
LDL Receptor
33%
Mammalian Cells
66%
Mechanistic Insight
33%
Myeloperoxidase Deficiency
33%
Newly Synthesized Proteins
33%
Potential Therapeutics
33%
Principal Investigator
66%
Protein Partners
33%
Regulated Proteolysis
33%
Saccharomyces Cerevisiae
33%
Therapeutic Intervention
66%
Ubiquitin Ligase
33%
Ubiquitin-mediated Proteolysis
33%
Ubiquitination
66%
Pharmacology, Toxicology and Pharmaceutical Science
Alpha 1 Antitrypsin
50%
Cystic Fibrosis
50%
Cystic Fibrosis Transmembrane Conductance Regulator
50%
Diseases
50%
Emphysema
50%
Familial Hypercholesterolemia
50%
Genetic Disorder
50%
Insulin Receptor
50%
Insulin Resistance
50%
Liver Disease
50%
Low Density Lipoprotein Receptor
50%
Myeloperoxidase
50%
Proteasome
50%
Saccharomyces cerevisiae
50%
Ubiquitin
50%
Ubiquitin Conjugating Enzyme
100%
Ubiquitin Protein Ligase
50%
Biochemistry, Genetics and Molecular Biology
Alpha 1-Antitrypsin
33%
Biochemistry
100%
Cystic Fibrosis
33%
Cystic Fibrosis Transmembrane Conductance Regulator
33%
Endoplasmic-Reticulum-Associated Protein Degradation
66%
Familial Hypercholesterolemia
33%
Genetics
33%
Insulin Receptor
33%
Insulin Resistance
33%
LDL Receptor
33%
Myeloperoxidase
33%
Proteasome
33%
Proteolysis
66%
Saccharomyces cerevisiae
33%
Ubiquitin
33%
Ubiquitin-Conjugating Enzyme
100%
Ubiquitination
66%